Get the Stockscreener App
0.3138
17.77%
-0.0678
After Hours:
.32
0.0062
+1.98%
Enzo Biochem Inc stock is traded at $0.3138, with a volume of 4.12M.
It is down -17.77% in the last 24 hours and down -33.25% over the past month.
Enzo Biochem Inc is a bioscience company. The firm manufactures, develops and sell their proprietary solutions and platforms to clinical laboratories, specialty clinics and researchers and physicians internationally. The company has one reportable segment, Products, which focuses on labeling and detection technologies from DNA to whole cell analysis, including a comprehensive portfolio of thousands of high-quality products, including antibodies, genomic probes, assays, biochemicals, and proteins.
See More
Previous Close:
$0.3816
Open:
$0.3702
24h Volume:
4.12M
Relative Volume:
14.51
Market Cap:
$18.29M
Revenue:
$30.31M
Net Income/Loss:
$-22.84M
P/E Ratio:
-0.6973
EPS:
-0.45
Net Cash Flow:
$-22.61M
1W Performance:
+20.32%
1M Performance:
-33.25%
6M Performance:
-72.23%
1Y Performance:
-72.71%
1-Day Range:
$0.3138
$0.40
1-Week Range:
$0.286
$0.419
52-Week Range:
$0.252
$1.275
Enzo Biochem Inc Stock (ENZ) Company Profile
Name
Enzo Biochem Inc
Sector
Industry
Phone
(516) 755-5500
Address
60 EXECUTIVE BLVD, FARMINGDALE, NY
Compare ENZ with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ENZ
Enzo Biochem Inc
|
0.3138 | 18.29M | 30.31M | -22.84M | -22.61M | -0.45 |
|
TMO
Thermo Fisher Scientific Inc
|
427.50 | 169.62B | 42.88B | 6.34B | 7.27B | 16.53 |
|
DHR
Danaher Corp
|
186.83 | 138.06B | 23.88B | 3.90B | 5.30B | 5.28 |
|
IDXX
Idexx Laboratories Inc
|
411.49 | 32.79B | 3.90B | 887.87M | 798.08M | 10.67 |
|
A
Agilent Technologies Inc
|
102.48 | 29.99B | 6.53B | 1.26B | 1.31B | 4.35 |
|
IQV
Iqvia Holdings Inc
|
143.91 | 26.61B | 15.41B | 1.37B | 2.11B | 7.50 |
Enzo Biochem Inc Stock (ENZ) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Oct-18-11 | Reiterated | Rodman & Renshaw | Mkt Outperform |
| Sep-23-09 | Initiated | Rodman & Renshaw | Mkt Outperform |
| Sep-13-07 | Initiated | Lazard Capital | Buy |
Enzo Biochem Inc Stock (ENZ) Latest News
The Zacks Analyst Blog AbbVie, The TJX, The Charles Schwab, Enzo Biochem and CVD Equipment - Yahoo Finance
Enzo Biochem (NYSE:ENZ) Now Covered by Analysts at StockNews.com - Defense World
Enzo Biochem (NYSE:ENZ) Now Covered by StockNews.com - Defense World
12 Health Care Stocks Moving In Wednesday's Pre-Market Session - Benzinga
Virtu Financial LLC Takes $35,000 Position in Enzo Biochem, Inc. (NYSE:ENZ) - Defense World
Enzo Biochem stock hits 52-week low at $0.33 amid market challenges By Investing.com - Investing.com South Africa
Enzo Biochem to Delist from NYSE, Move to OTCQX - TipRanks
Enzo Biochem stock hits 52-week low at $0.33 amid market challenges - Investing.com Australia
StockNews.com Begins Coverage on Enzo Biochem (NYSE:ENZ) - Defense World
Enzo Biochem to delist from NYSE, move to OTCQX market By Investing.com - Investing.com South Africa
Enzo Biochem to voluntarily delist from NYSE and transfer trading of shares to OTCQX; shares fall - MSN
Enzo Biochem to delist from NYSE, move to OTCQX market - Investing.com India
Enzo Biochem (ENZ) to Voluntarily Delist from NYSE, Move to OTCQ - GuruFocus
Enzo Biochem Announces Notification to New York Stock Exchange of Intention to Voluntarily Delist Common Stock and Transfer Trading of Shares to OTCQX - The Manila Times
Enzo Biochem Announces Notification to New York Stock - GlobeNewswire
Enzo Biochem Announces Notification to New York Stock Exchange of Intention to Voluntarily - Bluefield Daily Telegraph
NYSE Delisting Alert: Enzo Biochem Moving to OTCQXWhat Shareholders Must Know - Stock Titan
$7.5M Enzo Biochem data breach class action settlement - Class Action Lawsuits
Here’s Why Enzo Biochem (ENZ) Declined in Q4 - Yahoo Finance
ENZ Stock Down Following Q2 Earnings, Revenues Decline Y/Y - Nasdaq
Enzo Biochem Inc (ENZ) Reports Q2 Fiscal 2025 Revenue of $7.3 Mi - GuruFocus.com
Enzo Biochem: Fiscal Q2 Earnings Snapshot - The Pioneer
Enzo Biochem Reports Decline in Quarterly Revenues - TipRanks
Enzo Biochem Inc. ($0.01 Par Value) (ENZ) reports earnings - Quartz
Enzo Biochem Stages Comeback: Q2 Shows 18% Growth, Key Segment Returns to Profit - StockTitan
12 Health Care Stocks Moving In Monday's After-Market Session - Benzinga
Enzo Biochem: Fiscal Q2 Earnings Snapshot -March 17, 2025 at 04:30 pm EDT - Marketscreener.com
ENZO BIOCHEM INC SEC 10-Q Report - TradingView
Enzo Biochem Reports Second Quarter Fiscal Year 2025 Results - GlobeNewswire
Protein Stability Analysis Market Future Business - openPR
Enzo Biochem (NYSE:ENZ) Coverage Initiated by Analysts at StockNews.com - Defense World
Enzo Biochem settles data breach class action $7.5 million - Claim Depot
Enzo Biochem, Inc. to Host Earnings Call - ACCESS Newswire
Enzo Biochem (NYSE:ENZ) Earns Hold Rating from Analysts at StockNews.com - The AM Reporter
Protein Stability Analysis Market Generated Opportunities, - openPR
Enzo Biochem, Inc.'s (NYSE:ENZ) 28% Share Price Plunge Could Signal Some Risk - Simply Wall St
Enzo Biochem stock hits 52-week low at $0.51 amid challenges - MSN
Enzo Biochem Inc Stock (ENZ) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.41%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):